Patty Murray
The Public Record
Patty Lynn Murray is a United States Senator from Washington, serving since 1993. A member of the Democratic Party, she has held various leadership positions in the Senate, including serving as the Senate's first female President pro tempore. Throughout her tenure, Murray has focused on issues such as education, healthcare, and women's rights, advocating for policies that support working families and promote economic growth.
I have a particular passion for early learning, and I want to hear where you stand on how the Federal Government can help ensure that every child is prepared for success in kindergarten.
I am going to want to know more about how you will enforce critical civil rights laws.
I am hopeful that you have learned more about it since then and are prepared to address it seriously.
I refuse to accept that, and I'm going to continue to hold the incoming administration to the highest ethical standards.
We owe it to the people we represent to make sure every nominee is not only qualified for the position...
How do companies distinguish between consumer complaints and adverse event reports, and do you believe that most companies report adverse events to the FDA?
I am glad that, in the absence of stricter Federal laws, the individual States like my home State of Washington have taken steps to restrict or reduce the use of certain ingredients.
I really commend their work to bring together so many stakeholders from the business and consumer community to develop the Personal Care Product Safety Act.
Congress has spent a great deal of time modernizing nearly every aspect of the Food, Drug and Cosmetic Act.
FDA has no authority to review or confirm the safety of the ingredients in fragrances used in cosmetics before they enter the market.
In spite of that explosive growth putting millions of products on the market, the FDA's authority has not changed.
I am really pleased that we are holding this hearing to talk about products that millions of consumers and families use each day.
The cosmetics portion of the law has barely been touched since it passed in 1938.
Maintaining our country's leadership in science and biomedical innovation is a top priority for all of us here.
This discrepancy has created an uneven playing field for innovative companies and laboratories, including many in Washington State, and uncertainty for patients and physicians.
I'm concerned that our regulatory system currently can't provide that assurance.
I'm excited about the President's Precision Medicine Initiative and the Vice President's Cancer Moonshot which can help ensure that the next generation of treatments and cures are developed right here in the United States.
But that promise cannot be realized unless doctors and patients have the assurance that when a test result demonstrates risk of a disease, provides an early diagnosis, or suggests a treatment, that result is correct and reliable.
Very concerned that this oversight currently proposed could impede patient access to existing high-quality or state-of-the-art tests and threaten needed innovation.
There is a special clientele that go to the Vet Centers, often people that do not want to have, for instance, a trail of medical records about the care that they are receiving.
I strongly believe that this is really an important service that would help greatly our Guard and Reserve members when they return home from deployments.





